This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer's 'Mad Money Lightning Round': Ameritrade Makes the Grade

To see a full "Mad Money" Recap, please click here .


Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Monday evening:

NitroMed (NTMD): "Ten million [shares] of it is short. ... I'm not backing away from NTMD. I think you should buy it."

Cell Genesys (CEGE): "Forget the Cell Genesys. (Cramer prefers Amgen (AMGN - Get Report).)

Powerwave Tech (PWAV): "Powerwave is the company that augments the towers from cell phones. ... I think you do a 'mon back* on the pullback."

World Fuel Services (INT): "There's really no edge to that stock. ... Let's ring the register and buy some higher quality."

Chesapeake Energy (CHK - Get Report): "The stock could actually go down to 25, and a lot of folks won't be able to take the pain. ... My take is that Chesapeake's a keeper."

Nektar Thearpeutics (NKTR): "Not for me."

Ameritrade (AMTD - Get Report): "One of the greatest plays on the Net. They're survivors, they put it together. Two thumbs up, way up."

Southwest (LUV): "Southwest is spiking here. I believe it could have a couple more days on the upside."

National City (NCC): "That is exactly what you should own when the Fed decides to stop this nonsense."

Equitable Resources (EQT): "This is one of those natural resource plays ... I think Equitable with a 2% yield is not attractive."

Constellation Brands (STZ): "I am not a chartist. This Constellation Brands has turned from one of the greatest stocks in the past five years to the House of Pain."

Atmel (ATML): "This is the kind of three-buck integrated circuit play that will put you in the [House of Pain]."

JDS Uniphase (JDSU - Get Report): "They are telling a compelling story. ... I like their different divisions. ... Perhaps maybe a baby bull."

Brown & Brown (BRO - Get Report): "Really good insurer. Doesn't get talked about enough. ... This company knows how to run a good business."
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
PWAV $0.06 0.00%
AMGN $172.74 0.00%
AMTD $36.54 0.00%
CBSH $46.73 0.00%
BRCM $51.56 0.00%

Markets

Chart of I:DJI
DOW 17,630.27 +189.68 1.09%
S&P 500 2,093.25 +25.61 1.24%
NASDAQ 5,089.2060 +49.43 0.98%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs